13-Nov-2025 7:00 AM CST - Business Wire KORU Medical Systems to Participate in Upcoming Investor Conferences KORU Medical Systems (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will be participating in three upcoming Investor Conferences. KORU Medicals management team is participating at the 16th Annual Craig-Hallum Alpha Select Conference on Tuesday, Nove
12-Nov-2025 3:05 PM CST - Business Wire KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights Third quarter 2025 net revenues of $10.4 million, a 27% increase over the prior year period Core business (Dom
22-Oct-2025 3:05 PM CST - Business Wire KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025 KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report third quarter 2025 financial results on Wednesday, November 12, 2025. KORU Medicals management will host a conference call and webcast at 4:30 p.m. ET that day to disc
6-Aug-2025 3:05 PM CST - Business Wire KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2025. Financial Highlights Second quarter 2025 net revenues of $10.2 million, a 21% increase over the prior year period Core bus
30-Jul-2025 3:05 PM CST - Business Wire KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the company will participate in the Canaccord Genuity 45th Annual Growth Conference on August 13th, 2025. KORU Medical's management is scheduled to present at the Canaccord Genuity 45th An
16-Jul-2025 3:05 PM CST - Business Wire KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025 KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report second quarter 2025 financial results on Wednesday, August 6, 2025. KORU Medicals management will host a conference call and webcast at 4:30 p.m. ET that day to discus
7-May-2025 3:05 PM CST - Business Wire KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights First quarter 2025 net revenues of $9.6 million, an 18% increase over the prior year period Core business (Domestic an
16-Apr-2025 3:05 PM CST - Business Wire KORU Medical Systems to Report First Quarter 2025 Financial Results on May 7, 2025 KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report first quarter 2025 financial results on Wednesday, May 7, 2025. KORU Medicals management will host a conference call and webcast at 4:30 p.m. ET that day to discuss th
12-Mar-2025 3:05 PM CST - Business Wire KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the fourth quarter and full year ended December 31, 2024. The Company also issued guidance for the full year 2025. Recent Highlights Fourth quarter 2024 net revenues of $8.8 mi
13-Nov-2025 7:00 AM CST - Business Wire KORU Medical Systems to Participate in Upcoming Investor Conferences KORU Medical Systems (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will be participating in three upcoming Investor Conferences. KORU Medicals management team is participating at the 16th Annual Craig-Hallum Alpha Select Conference on Tuesday, Nove
12-Nov-2025 3:05 PM CST - Business Wire KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights Third quarter 2025 net revenues of $10.4 million, a 27% increase over the prior year period Core business (Dom
22-Oct-2025 3:05 PM CST - Business Wire KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025 KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report third quarter 2025 financial results on Wednesday, November 12, 2025. KORU Medicals management will host a conference call and webcast at 4:30 p.m. ET that day to disc
6-Aug-2025 3:05 PM CST - Business Wire KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2025. Financial Highlights Second quarter 2025 net revenues of $10.2 million, a 21% increase over the prior year period Core bus
30-Jul-2025 3:05 PM CST - Business Wire KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the company will participate in the Canaccord Genuity 45th Annual Growth Conference on August 13th, 2025. KORU Medical's management is scheduled to present at the Canaccord Genuity 45th An
16-Jul-2025 3:05 PM CST - Business Wire KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025 KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report second quarter 2025 financial results on Wednesday, August 6, 2025. KORU Medicals management will host a conference call and webcast at 4:30 p.m. ET that day to discus
7-May-2025 3:05 PM CST - Business Wire KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights First quarter 2025 net revenues of $9.6 million, an 18% increase over the prior year period Core business (Domestic an
16-Apr-2025 3:05 PM CST - Business Wire KORU Medical Systems to Report First Quarter 2025 Financial Results on May 7, 2025 KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report first quarter 2025 financial results on Wednesday, May 7, 2025. KORU Medicals management will host a conference call and webcast at 4:30 p.m. ET that day to discuss th
12-Mar-2025 3:05 PM CST - Business Wire KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the fourth quarter and full year ended December 31, 2024. The Company also issued guidance for the full year 2025. Recent Highlights Fourth quarter 2024 net revenues of $8.8 mi
